Monocytes, neutrophils, and platelets cooperate to initiate and propagate venous thrombosis in mice in vivo

Marie-Luise von Brühl, Konstantin Stark, Alexander Steinhart, Sue Chandraratne, Ildiko Konrad, Michael Lorenz, Alexander Khandoga, Anca Tirniceriu, Raffaele Coletti, Maria Köllnberger, Robert A Byrne, Iina Laitinen, Axel Walch, Alexander Brill, Susanne Pfeiler, Davit Manukyan, Siegmund Braun, Philipp Lange, Julia Riegger, Jerry Ware, Annekathrin Eckart, Selgai Haidari, Martina Rudelius, Christian Schulz, Katrin Echtler, Volker Brinkmann, Markus Schwaiger, Klaus T Preissner, Denisa D Wagner, Nigel Mackman, Bernd Engelmann, Steffen Massberg, Marie-Luise von Brühl, Konstantin Stark, Alexander Steinhart, Sue Chandraratne, Ildiko Konrad, Michael Lorenz, Alexander Khandoga, Anca Tirniceriu, Raffaele Coletti, Maria Köllnberger, Robert A Byrne, Iina Laitinen, Axel Walch, Alexander Brill, Susanne Pfeiler, Davit Manukyan, Siegmund Braun, Philipp Lange, Julia Riegger, Jerry Ware, Annekathrin Eckart, Selgai Haidari, Martina Rudelius, Christian Schulz, Katrin Echtler, Volker Brinkmann, Markus Schwaiger, Klaus T Preissner, Denisa D Wagner, Nigel Mackman, Bernd Engelmann, Steffen Massberg

Abstract

Deep vein thrombosis (DVT) is a major cause of cardiovascular death. The sequence of events that promote DVT remains obscure, largely as a result of the lack of an appropriate rodent model. We describe a novel mouse model of DVT which reproduces a frequent trigger and resembles the time course, histological features, and clinical presentation of DVT in humans. We demonstrate by intravital two-photon and epifluorescence microscopy that blood monocytes and neutrophils crawling along and adhering to the venous endothelium provide the initiating stimulus for DVT development. Using conditional mutants and bone marrow chimeras, we show that intravascular activation of the extrinsic pathway of coagulation via tissue factor (TF) derived from myeloid leukocytes causes the extensive intraluminal fibrin formation characteristic of DVT. We demonstrate that thrombus-resident neutrophils are indispensable for subsequent DVT propagation by binding factor XII (FXII) and by supporting its activation through the release of neutrophil extracellular traps (NETs). Correspondingly, neutropenia, genetic ablation of FXII, or disintegration of NETs each confers protection against DVT amplification. Platelets associate with innate immune cells via glycoprotein Ibα and contribute to DVT progression by promoting leukocyte recruitment and stimulating neutrophil-dependent coagulation. Hence, we identified a cross talk between monocytes, neutrophils, and platelets responsible for the initiation and amplification of DVT and for inducing its unique clinical features.

Figures

Figure 1.
Figure 1.
A novel clinically relevant mouse model of DVT. (A) Scanning electron microscopic images of the IVC. Images taken immediately after (baseline) and 1 h after partial ligation in the IVC illustrate the intact endothelial cell lining of the IVC without endothelial disruption. Bars, 5 µm. Shown is a representative of n = 3 experiments. (B) Assessment of blood flow in the IVC in response to partial ligation (n = 16). Dots represent individual experiments; lines show the mean of each group. (C) Evaluation of DVT by contrast-enhanced computed tomography (CT) 48 h after flow restriction in the IVC (also see Video 1). CT images were acquired in a sagittal projection using a small animal CT scanner. Right: animal with DVT at 48 h after flow restriction. The dotted line shows the IVC in the abdominal cavity. Arrowheads point to the lack of contrast agent, indicating thrombus formation. Left: control animal with sham ligation showing continuous contrast filling of the IVC. Shown is a representative of n = 3 experiments. (D) Weight (milligrams) of harvested IVC thrombi 48 h after DVT induction in C57BL/6 (n = 6), SV129 mice (n = 4), and after enoxaparin treatment (n = 5). Dots represent individual experiments; lines show the mean of each group. (E) Macroscopic and microscopic assessment of venous thrombi after 48 h of flow restriction in C57BL/6 animals. Regions of red (R) and white (W) thrombus can be distinguished macroscopically (left) and microscopically in a longitudinal (middle) and cross section (right) stained with van Gieson (vG). The thrombus shows the typical white and erythrocyte-rich red layers. Bars: (left and middle) 1 mm; (right) 100 µm. Shown is a representative of n = 10 experiments. (F) Excised thrombosed IVC obtained 48 h after induction of DVT in C57BL/6 animals. Regions of red and white thrombus can be distinguished microscopically in a longitudinal HE-stained section. Carstairs staining (CS) is demonstrating the layers of fibrin, platelets, and red blood cells throughout the thrombus, and DAPI staining illustrates the distribution of leukocytes in clusters (arrow) and layers (arrowhead). Bars, 1 mm. Shown is a representative of n = 3 experiments.
Figure 2.
Figure 2.
Leukocytes are recruited during the early phase of venous thrombosis to the intact endothelial surface. (A) Leukocyte accumulation in DVT induced by 48 h of flow restriction. vG (top left) and immunohistochemical stainings (middle and right, top and bottom) for Ly6G+ MPO+ neutrophils and F4/80+ monocytes. Nuclei are counterstained with DAPI. Bars, 50 µm. The bottom left shows the quantification of neutrophils and monocytes. Results are mean ± SEM (n = 3). (B) Scanning electron microscopic images taken directly after partial IVC ligation showing the intact endothelium. After 6 h, a carpet composed of cell aggregates and fibrin can be visualized on the endothelial surface. Bars, 5 µm. (C) TEM images of venous vessels showing the anticoagulant endothelial cell lining (pseudocolored in yellow). Bar, 5 µm. Detail is shown in the right image. (D) Histological analyses of the IVC 6 h after flow reduction examining leukocyte recruitment in the early phase of venous thrombus formation. Histological sections in three different stainings (HE, vG, and MSB). Bars: (top row) 20 µm; (bottom row) 10 µm. Data are representative of n = 3 experiments per group.
Figure 3.
Figure 3.
Neutrophils and monocytes are the main leukocyte subsets accumulating during the initiation of DVT. (A) Neutrophils (green) crawling on the vessel wall (red) of the IVC 2 h after DVT induction visualized by two-photon microscopy. Tracks of individual neutrophils are shown in white (also see Video 3). Bar, 50 µm. Shown is a representative of n = 3 experiments. (B) Time course of early leukocyte–endothelial interaction within 6 h of flow restriction as evaluated by intravital microscopy in WT animals using Acridine orange (WT + acr orange). Baseline images were taken before ligation. LysM-eGFP mice were used to evaluate neutrophils and CX3CR1-eGFP mice were analyzed to evaluate monocytes. Bars, 100 µm. Shown is a representative of n = 5 experiments. (C) Dynamics of the recruitment of distinct subsets of innate immune cells during DVT initiation determined in vivo by video microscopy. Rolling and firm adhesion of leukocytes are given as number per square millimeter. Results are shown as mean ± SEM (n = 5 per group). (D, Left) Relative frequency of neutrophils and monocytes at 6 h of flow restriction as assessed by intravital video microscopy. Results are mean ± SEM (n = 5 per group). (D, Right) Representative images taken by intravital epifluorescence microscopy showing blood cell recruitment 6 h after flow restriction in the IVC. Neutrophils were visualized in LysM-eGFP mice. The number of recruited monocytes was assessed using CX3CR1-eGFP mice. In both strains of mice, all leukocytes (irrespective of their lineage) were identified by counterstaining with the fluorescent dye Acridine orange (pseudocolored in red). Bars, 100 µm. (E) FACS analysis of blood in LysM-eGFP and CX3CR1-eGFP mice without IVC ligation using a neutrophil specific anti-Ly6G antibody. (F) Intravital two-photon microscopy of LysM-eGFP and CX3CR1-eGFP with PE-labeled anti-Ly6G antibody 6 h after DVT induction (left). Bars, 50 µm. Quantification of Ly6G+ GFP+ double-positive cells in these mouse strains (right; Videos 4 and 5). Shown is a representative of n = 3 experiments.
Figure 4.
Figure 4.
Crucial role of P-selectin for leukocyte accumulation in DVT. (A) RT-PCR of trafficking molecules in the IVC in response to flow restriction at baseline or 6 and 48 h after DVT induction (n = 5 per group). Results are shown as mean ± standard deviation. (B) RT-PCR of P-selectin in the IVC at baseline or 6 and 48 h after DVT induction (n = 5 per group). Results are shown as mean ± standard deviation. (C) Representative immunohistochemical stainings of the IVC endothelium 48 h after DVT induction showing P-selectin and vWF on the endothelial surface. Nuclei are counterstained with DAPI. Bars, 50 µm. (D, Left) Representative in vivo images of adherent leukocytes in C57BL/6 and SELP−/− mice 6 h after induction of DVT. Leukocytes were stained with Acridine orange and visualized by intravital video microscopy (arrowhead indicates aggregates; arrows indicate single adherent cells). Bars, 100 µm. (D, Right) Quantitative analysis of firm leukocyte adhesion, 6 h after flow restriction. Firm cell adhesion is given in number per square millimeters of C57BL/6 (n = 5) and SELP−/− (n = 7). Data are shown as mean ± SEM. (E, Left) Representative images of the excised IVC including the thrombus after 48 h in C57BL/6 and SELP−/− mice. Bars, 1 mm. (E, Right) Thrombus weight in C57BL/6 (n = 8) and SELP−/− mice (n = 4) 48 h after DVT induction. Dots represent individual experiments; lines show the mean of each group. (F) Histological analysis of the harvested IVC thrombi 48 h after flow reduction given as thrombus load in square millimeters (n = 5). plt, platelets. Data are shown as mean ± SEM.
Figure 5.
Figure 5.
Blood cell TF is indispensable for venous thrombosis. (A) Fibrin formation during DVT development was measured in vivo by intravital microscopy in control HCV and low-hTF mice using an Alexa Fluor 488–labeled specific fibrin antibody. Measurements were performed after 1–6 h of flow restriction. Representative images acquired by intravital microscopy of the IVC are shown on the right (fibrin pseudocolored in yellow). Bars, 100 µm. n = 3 per group. Data are shown as mean ± SEM. (B) Thrombus load was assessed on vG-stained serial sections in low-hTF (n = 10) and HCV mice (n = 5), as well as in bone marrow chimeras lacking blood cell TF (n = 6). Thrombus load is given as square millimeters. Dots represent individual experiments; lines show the mean of each group. (C) Assessment of leukocyte recruitment 6 h after flow reduction by intravital microscopy. Leukocytes were visualized using i.v. application of the fluorescent dye rhodamine 6G (pseudocolored in green). The number of adherent cells is given as number per square millimeters (n = 3 per group). Representative in vivo images are shown on the right. Bar, 100 µm. Data are shown as mean ± SEM. (D) Thrombus weight (at 48 h) in control mice (n = 10) and in conditional mutants (LysMCre-TFflox/flox) lacking TF in LysM+ myeloid cells (n = 12). Dots represent individual experiments; lines show the mean of each group. (E) Immunohistochemical detection of TF protein (red) on Ly6G-positive (green) and -negative cells in thrombi at 48 h of flow restriction, indicating TF expression on neutrophils (yellow; TF+ and Ly6G+) and monocytes (red; TF+ and Ly6G−). LysMCre-TFflox/flox mice (bottom) were used as negative control. Nuclei are stained with DAPI. Bars, 100 µm. Shown is a representative of n = 3 experiments.
Figure 6.
Figure 6.
NETs propagate DVT in vivo. (A) Leukocyte accumulation in vivo at 6 h of flow restriction in the IVC of LysM-eGFP mice treated with control antibody or the anti-Ly6G mAb to deplete neutrophils. Arrowhead: aggregated neutrophils; arrows: single, adherent cells. Bars, 100 µm. (B) Thrombus weight 48 h after DVT induction in isotype and anti-Ly6G–treated WT mice (n = 6 per group). Dots represent individual experiments; lines show the mean of each group. (C) Representative image of n = 3 experiments of intravital microscopy 3 or 48 h after flow reduction showing Sytox Green+ NETs in the IVC. Bars, 50 µm. (D) Visualization of NETs in vivo by 2-photon microscopy. Ly6G-positive neutrophils (green, FITC anti-Ly6G antibody) attached to the vessel wall (blue) release Sytox orange–positive (red) NET structures inside the IVC 4 h after flow reduction (also see Video 7). Sytox orange–positive nuclei correspond to dying neutrophils, which have not (yet) exposed their DNA to the extracellular space. Arrowhead: extracellular DNA; arrow: neutrophil. Bar, 50 µm. (E) Immunohistochemical visualization of NETs by staining for DNA (Hoechst), MPO, NE, and histones (H2A-H2B-DNA, H3) in the IVC of WT mice 48 h after induction of DVT. Hoechst+ DNA originating from MPO+NE+ neutrophils (arrows) could be detected. Arrows, nuclei; arrowheads, NET fibers. Bars, 10 µm. (F) Number of NETs in neutropenic mice were quantified in thrombi after treatment with anti-Ly6G and isotype control antibody (n = 3 per group). Data are shown as mean ± SEM. (G) Representative images of WT thrombi stained with Hoechst after DNase1 treatment. Arrowhead, NET fiber. Bars, 10 µm. Shown is a representative of n = 3 experiments. (H) After injection of DNase1, thrombus weight (left) in the IVC was determined after 48 h of flow restriction. Dots represent individual experiments; lines show the mean of each group. Quantification of NETs is also shown (right) as mean ± SEM. Data were obtained in WT injected with normal saline i.v. (n = 14) or DNase1 (n = 6). (I) Quantification of NETs at 48 h in the enoxaparin-treated animals (n = 4 per group). Data are shown as mean ± SEM.
Figure 7.
Figure 7.
Platelet recruitment supports DVT formation in vivo. (A) Immunohistological cross sections of the IVC 48 h after DVT induction display platelet accumulation (CD41+) within the thrombus. Nuclei are counterstained with DAPI. Bars, 200 µm. Representative of n = 3 experiments. (B) Representative images of intravital video microscopy of blood cell recruitment taken at 6 h after DVT induction. Arrowheads: thrombi; arrows: single, adherent cells. Platelets, red (rhodamine B); leukocytes, green (Acridine orange). Bars, 100 µm. (C) Time-lapse images of the developing thrombus (arrowheads) visualized by two-photon microscopy 6 h after DVT induction. Platelets (yellow) and neutrophils (green) are recruited from the bloodstream (blue) to the vessel wall (red; see also Video 8). (D) Platelet–leukocyte interaction was determined by intravital microscopy in C57BL/6 and IL4-R/Iba mice after 6 h of flow restriction. Bars: (left) 50 µm; (right) 100 µm. The right panel shows quantification of colocalization of leukocytes and platelets in WT (n = 5) and IL4-R/Iba mice (n = 4). Data are shown as mean ± SEM. (E) Representative images obtained by video microscopy 6 h after DVT induction in IL4-R/Iba and control animals (n = 3 per group). Platelets are pseudocolored in red (DyLight488-labeled GPIbβ antibody) and leukocytes in green (Acridine orange). Bars, 100 µm. (F) Representative images taken by intravital microscopy of WT mice 1 h after induction of venous (left) and 5 min after arterial (right) thrombosis. Arrows show platelet aggregate formation. Leukocytes are fluorescently labeled (green) by i.v. application of Acridine orange. Bars, 50 µm. (G) Quantitative analysis of platelet (plt) and leukocyte (lcs) accumulation (as percentage of WT controls) in IL4-R/Iba (n = 3) and WT mice (n = 5). Data are shown as mean ± SEM. (H) Thrombus weight at 48 h after DVT induction in C57BL/6 (n = 8) and IL4-R/Iba mice (n = 5). Dots represent individual experiments; lines show the mean of each group.
Figure 8.
Figure 8.
Platelets induce NET formation, which triggers FXIIa-dependent thrombus propagation. (A) Freshly isolated human neutrophils were incubated with platelet supernatant. Cells were stained with a primary antibody directed against DNA–histone complexes and DAPI and visualized by confocal microscopy. Incubation with DNase1 where indicated. Bars, 50 µm. Arrowheads, cell nucleus; arrows, NET. (B) The total number of NETs (left) and NETs per leukocyte (right) was quantified on cross sections of thrombi 48 h after flow restriction in IL4-R/Iba mice and WT animals (n = 3 per group). Data are shown as mean ± SEM. (C) Analysis of thrombus formation (milligrams) in the IVC of C57BL/6 (n = 9), FXII−/− deficient (n = 7), and FXI−/− deficient mice (n = 7) 48 h after flow reduction. Dots represent individual experiments; lines show the mean of each group. (D) Quantification of fibrin density as percentage of fibrin-covered area in the IVC thrombus (n = 4 per group). Data are shown as mean ± SEM. (E) The effects of co-incubation of activated platelets (P) and neutrophils (N) on FXII activation in vitro. NETosis was inhibited by an antibody directed against the H2A–H2B–DNA complex. Data are shown as mean ± SEM. (F) Confocal visualization of FXII on NETs, released from isolated human neutrophils. Arrow, FXII bound to Sytox Green+ NETs. Bars, 10 µm.

References

    1. Ammollo C.T., Semeraro F., Xu J., Esmon N.L., Esmon C.T. 2011. Extracellular histones increase plasma thrombin generation by impairing thrombomodulin-dependent protein C activation. J. Thromb. Haemost. 9:1795–1803 10.1111/j.1538-7836.2011.04422.x
    1. Angelillo-Scherrer A., de Frutos P., Aparicio C., Melis E., Savi P., Lupu F., Arnout J., Dewerchin M., Hoylaerts M., Herbert J., et al. 2001. Deficiency or inhibition of Gas6 causes platelet dysfunction and protects mice against thrombosis. Nat. Med. 7:215–221 10.1038/84667
    1. Brill A., Fuchs T.A., Chauhan A.K., Yang J.J., De Meyer S.F., Köllnberger M., Wakefield T.W., Lämmle B., Massberg S., Wagner D.D. 2011. von Willebrand factor-mediated platelet adhesion is critical for deep vein thrombosis in mouse models. Blood. 117:1400–1407 10.1182/blood-2010-05-287623
    1. Brinkmann V., Reichard U., Goosmann C., Fauler B., Uhlemann Y., Weiss D.S., Weinrauch Y., Zychlinsky A. 2004. Neutrophil extracellular traps kill bacteria. Science. 303:1532–1535 10.1126/science.1092385
    1. Bucek R.A., Reiter M., Quehenberger P., Minar E. 2002. C-reactive protein in the diagnosis of deep vein thrombosis. Br. J. Haematol. 119:385–389 10.1046/j.1365-2141.2002.03886.x
    1. Cheng Q., Tucker E.I., Pine M.S., Sisler I., Matafonov A., Sun M.F., White-Adams T.C., Smith S.A., Hanson S.R., McCarty O.J., et al. 2010. A role for factor XIIa-mediated factor XI activation in thrombus formation in vivo. Blood. 116:3981–3989 10.1182/blood-2010-02-270918
    1. Clark S.R., Ma A.C., Tavener S.A., McDonald B., Goodarzi Z., Kelly M.M., Patel K.D., Chakrabarti S., McAvoy E., Sinclair G.D., et al. 2007. Platelet TLR4 activates neutrophil extracellular traps to ensnare bacteria in septic blood. Nat. Med. 13:463–469 10.1038/nm1565
    1. Clausen B.E., Burkhardt C., Reith W., Renkawitz R., Förster I. 1999. Conditional gene targeting in macrophages and granulocytes using LysMcre mice. Transgenic Res. 8:265–277 10.1023/A:1008942828960
    1. Cohen A.T., Agnelli G., Anderson F.A., Arcelus J.I., Bergqvist D., Brecht J.G., Greer I.A., Heit J.A., Hutchinson J.L., Kakkar A.K., et al. ; VTE Impact Assessment Group in Europe (VITAE) 2007. Venous thromboembolism (VTE) in Europe. The number of VTE events and associated morbidity and mortality. Thromb. Haemost. 98:756–764
    1. Day S.M., Reeve J.L., Pedersen B., Farris D.M., Myers D.D., Im M., Wakefield T.W., Mackman N., Fay W.P. 2005. Macrovascular thrombosis is driven by tissue factor derived primarily from the blood vessel wall. Blood. 105:192–198 10.1182/blood-2004-06-2225
    1. Diaz J.A., Hawley A.E., Alvarado C.M., Berguer A.M., Baker N.K., Wrobleski S.K., Wakefield T.W., Lucchesi B.R., Myers D.D., Jr 2010. Thrombogenesis with continuous blood flow in the inferior vena cava. A novel mouse model. Thromb. Haemost. 104:366–375 10.1160/TH09-09-0672
    1. Eitzman D.T., Westrick R.J., Nabel E.G., Ginsburg D. 2000. Plasminogen activator inhibitor-1 and vitronectin promote vascular thrombosis in mice. Blood. 95:577–580
    1. Esmon C.T. 2009. Basic mechanisms and pathogenesis of venous thrombosis. Blood Rev. 23:225–229 10.1016/j.blre.2009.07.002
    1. Faust N., Varas F., Kelly L.M., Heck S., Graf T. 2000. Insertion of enhanced green fluorescent protein into the lysozyme gene creates mice with green fluorescent granulocytes and macrophages. Blood. 96:719–726
    1. Fuchs T.A., Brill A., Duerschmied D., Schatzberg D., Monestier M., Myers D.D., Jr, Wrobleski S.K., Wakefield T.W., Hartwig J.H., Wagner D.D. 2010. Extracellular DNA traps promote thrombosis. Proc. Natl. Acad. Sci. USA. 107:15880–15885 10.1073/pnas.1005743107
    1. Furie B., Furie B.C. 2007. In vivo thrombus formation. J. Thromb. Haemost. 5:12–17 10.1111/j.1538-7836.2007.02482.x
    1. Gailani D., Lasky N.M., Broze G.J.J., Jr 1997. A murine model of factor XI deficiency. Blood Coagul. Fibrinolysis. 8:134–144 10.1097/00001721-199703000-00008
    1. Garcia-Romo G.S., Caielli S., Vega B., Connolly J., Allantaz F., Xu Z., Punaro M., Baisch J., Guiducci C., Coffman R.L., et al. 2011. Netting neutrophils are major inducers of type I IFN production in pediatric systemic lupus erythematosus. Sci. Transl. Med. 3:ra20 10.1126/scitranslmed.3001201
    1. Geerts W.H., Code K.I., Jay R.M., Chen E., Szalai J.P. 1994. A prospective study of venous thromboembolism after major trauma. N. Engl. J. Med. 331:1601–1606 10.1056/NEJM199412153312401
    1. Griep M.A., Fujikawa K., Nelsestuen G.L. 1985. Binding and activation properties of human factor XII, prekallikrein, and derived peptides with acidic lipid vesicles. Biochemistry. 24:4124–4130 10.1021/bi00336a047
    1. Heit J.A. 2008. The epidemiology of venous thromboembolism in the community. Arterioscler. Thromb. Vasc. Biol. 28:370–372 10.1161/ATVBAHA.108.162545
    1. Heit J.A., Kobbervig C.E., James A.H., Petterson T.M., Bailey K.R., Melton L.J., III 2005. Trends in the incidence of venous thromboembolism during pregnancy or postpartum: a 30-year population-based study. Ann. Intern. Med. 143:697–706
    1. Hughes R.J., Hopkins R.J., Hill S., Weatherall M., Van de Water N., Nowitz M., Milne D., Ayling J., Wilsher M., Beasley R. 2003. Frequency of venous thromboembolism in low to moderate risk long distance air travellers: the New Zealand Air Traveller’s Thrombosis (NZATT) study. Lancet. 362:2039–2044 10.1016/S0140-6736(03)15097-0
    1. Jung S., Aliberti J., Graemmel P., Sunshine M.J., Kreutzberg G.W., Sher A., Littman D.R. 2000. Analysis of fractalkine receptor CX(3)CR1 function by targeted deletion and green fluorescent protein reporter gene insertion. Mol. Cell. Biol. 20:4106–4114 10.1128/MCB.20.11.4106-4114.2000
    1. Kanaji T., Russell S., Ware J. 2002. Amelioration of the macrothrombocytopenia associated with the murine Bernard-Soulier syndrome. Blood. 100:2102–2107 10.1182/blood-2002-03-0997
    1. Konings J., Govers-Riemslag J.W., Philippou H., Mutch N.J., Borissoff J.I., Allan P., Mohan S., Tans G., Ten Cate H., Ariëns R.A. 2011. Factor XIIa regulates the structure of the fibrin clot independently of thrombin generation through direct interaction with fibrin. Blood. 118:3942–3951 10.1182/blood-2011-03-339572
    1. Livak K.J., Schmittgen T.D. 2001. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Δ Δ C(T)) Method. Methods. 25:402–408 10.1006/meth.2001.1262
    1. Losman M.J., Fasy T.M., Novick K.E., Monestier M. 1992. Monoclonal autoantibodies to subnucleosomes from a MRL/Mp(-)+/+ mouse. Oligoclonality of the antibody response and recognition of a determinant composed of histones H2A, H2B, and DNA. J. Immunol. 148:1561–1569
    1. Mackman N. 2008. Triggers, targets and treatments for thrombosis. Nature. 451:914–918 10.1038/nature06797
    1. Mammen E.F. 1992. Pathogenesis of venous thrombosis. Chest. 102:640S–644S 10.1378/chest.102.6.640S
    1. Manly D.A., Boles J., Mackman N. 2011. Role of tissue factor in venous thrombosis. Annu. Rev. Physiol. 73:515–525 10.1146/annurev-physiol-042210-121137
    1. Massberg S., Enders G., Leiderer R., Eisenmenger S., Vestweber D., Krombach F., Messmer K. 1998. Platelet-endothelial cell interactions during ischemia/reperfusion: the role of P-selectin. Blood. 92:507–515
    1. Massberg S., Brand K., Grüner S., Page S., Müller E., Müller I., Bergmeier W., Richter T., Lorenz M., Konrad I., et al. 2002. A critical role of platelet adhesion in the initiation of atherosclerotic lesion formation. J. Exp. Med. 196:887–896 10.1084/jem.20012044
    1. Massberg S., Gawaz M., Grüner S., Schulte V., Konrad I., Zohlnhöfer D., Heinzmann U., Nieswandt B. 2003. A crucial role of glycoprotein VI for platelet recruitment to the injured arterial wall in vivo. J. Exp. Med. 197:41–49 10.1084/jem.20020945
    1. Massberg S., Grahl L., von Bruehl M.L., Manukyan D., Pfeiler S., Goosmann C., Brinkmann V., Lorenz M., Bidzhekov K., Khandagale A.B., et al. 2010. Reciprocal coupling of coagulation and innate immunity via neutrophil serine proteases. Nat. Med. 16:887–896 10.1038/nm.2184
    1. Moll S., Mackman N. 2008. Venous thromboembolism: a need for more public awareness and research into mechanisms. Arterioscler. Thromb. Vasc. Biol. 28:367–369 10.1161/ATVBAHA.108.163097
    1. Myers D., Jr, Farris D., Hawley A., Wrobleski S., Chapman A., Stoolman L., Knibbs R., Strieter R., Wakefield T. 2002. Selectins influence thrombosis in a mouse model of experimental deep venous thrombosis. J. Surg. Res. 108:212–221 10.1006/jsre.2002.6552
    1. Pal P.K., Starr T., Gertler M.M. 1983. Neutralization of heparin by histone and its subfractions. Thromb. Res. 31:69–79 10.1016/0049-3848(83)90008-7
    1. Parry G.C., Erlich J.H., Carmeliet P., Luther T., Mackman N. 1998. Low levels of tissue factor are compatible with development and hemostasis in mice. J. Clin. Invest. 101:560–569 10.1172/JCI814
    1. Pauer H.U., Renné T., Hemmerlein B., Legler T., Fritzlar S., Adham I., Müller-Esterl W., Emons G., Sancken U., Engel W., Burfeind P. 2004. Targeted deletion of murine coagulation factor XII gene-a model for contact phase activation in vivo. Thromb. Haemost. 92:503–508
    1. Pawlinski R., Tencati M., Holscher T., Pedersen B., Voet T., Tilley R.E., Marynen P., Mackman N. 2007. Role of cardiac myocyte tissue factor in heart hemostasis. J. Thromb. Haemost. 5:1693–1700 10.1111/j.1538-7836.2007.02649.x
    1. Pawlinski R., Wang J.G., Owens A.P., III, Williams J., Antoniak S., Tencati M., Luther T., Rowley J.W., Low E.N., Weyrich A.S., Mackman N. 2010. Hematopoietic and nonhematopoietic cell tissue factor activates the coagulation cascade in endotoxemic mice. Blood. 116:806–814 10.1182/blood-2009-12-259267
    1. Payling Weight H., Osborn S.B., Edmonds D. 1951. Effect of postoperative bed rest and early ambulation on the rate of venous blood-flow. Lancet. 257:22–25 10.1016/S0140-6736(51)93496-4
    1. PEP-Group 2000. Prevention of pulmonary embolism and deep vein thrombosis with low dose aspirin: Pulmonary Embolism Prevention (PEP) trial. Lancet. 355:1295–1302 10.1016/S0140-6736(00)02110-3
    1. Ramacciotti E., Blackburn S., Hawley A.E., Vandy F., Ballard-Lipka N., Stabler C., Baker N., Guire K.E., Rectenwald J.E., Henke P.K., et al. 2011. Evaluation of soluble P-selectin as a marker for the diagnosis of deep venous thrombosis. Clin. Appl. Thromb. Hemost. 17:425–431 10.1177/1076029611405032
    1. Reinhardt C., von Brühl M.L., Manukyan D., Grahl L., Lorenz M., Altmann B., Dlugai S., Hess S., Konrad I., Orschiedt L., et al. 2008. Protein disulfide isomerase acts as an injury response signal that enhances fibrin generation via tissue factor activation. J. Clin. Invest. 118:1110–1122
    1. Roger V.L., Go A.S., Lloyd-Jones D.M., Adams R.J., Berry J.D., Brown T.M., Carnethon M.R., Dai S., de Simone G., Ford E.S., et al. ; American Heart Association Statistics Committee and Stroke Statistics Subcommittee 2011. Heart disease and stroke statistics—2011 update: a report from the American Heart Association. Circulation. 123:e18–e209 10.1161/CIR.0b013e3182009701
    1. Roumen-Klappe E.M., Janssen M.C., Van Rossum J., Holewijn S., Van Bokhoven M.M., Kaasjager K., Wollersheim H., Den Heijer M. 2009. Inflammation in deep vein thrombosis and the development of post-thrombotic syndrome: a prospective study. J. Thromb. Haemost. 7:582–587 10.1111/j.1538-7836.2009.03286.x
    1. Sevitt S. 1970. Organic canalisation and vascularisation of deep vein thrombi studied with dyed-micropaque injected at necropsy. J. Pathol. Pi
    1. Sevitt S. 1974. The structure and growth of valve-pocket thrombi in femoral veins. J. Clin. Pathol. 27:517–528 10.1136/jcp.27.7.517
    1. Silverstein M.D., Heit J.A., Mohr D.N., Petterson T.M., O’Fallon W.M., Melton L.J., III 1998. Trends in the incidence of deep vein thrombosis and pulmonary embolism: a 25-year population-based study. Arch. Intern. Med. 158:585–593 10.1001/archinte.158.6.585
    1. Smeeth L., Cook C., Thomas S., Hall A.J., Hubbard R., Vallance P. 2006. Risk of deep vein thrombosis and pulmonary embolism after acute infection in a community setting. Lancet. 367:1075–1079 10.1016/S0140-6736(06)68474-2
    1. Stewart G.J., Ritchie W.G., Lynch P.R. 1974. Venous endothelial damage produced by massive sticking and emigration of leukocytes. Am. J. Pathol. 74:507–532
    1. Varma M.R., Varga A.J., Knipp B.S., Sukheepod P., Upchurch G.R., Kunkel S.L., Wakefield T.W., Henke P.K. 2003. Neutropenia impairs venous thrombosis resolution in the rat. J. Vasc. Surg. 38:1090–1098 10.1016/S0741-5214(03)00431-2
    1. Wakefield T.W., Strieter R.M., Wilke C.A., Kadell A.M., Wrobleski S.K., Burdick M.D., Schmidt R., Kunkel S.L., Greenfield L.J. 1995. Venous thrombosis-associated inflammation and attenuation with neutralizing antibodies to cytokines and adhesion molecules. Arterioscler. Thromb. Vasc. Biol. 15:258–268 10.1161/01.ATV.15.2.258
    1. Wang X., Smith P.L., Hsu M.Y., Ogletree M.L., Schumacher W.A. 2006. Murine model of ferric chloride-induced vena cava thrombosis: evidence for effect of potato carboxypeptidase inhibitor. J. Thromb. Haemost. 4:403–410 10.1111/j.1538-7836.2006.01703.x
    1. Ward C.M., Tetaz T.J., Andrews R.K., Berndt M.C. 1997. Binding of the von Willebrand factor A1 domain to histone. Thromb. Res. 86:469–477 10.1016/S0049-3848(97)00096-0
    1. Warlow C., Ogston D., Douglas A.S. 1976. Deep venous thrombosis of the legs after strokes: Part 2-Natural history. BMJ. 1:1181–1183 10.1136/bmj.1.6019.1181
    1. Wright H.P., Osborn S.B., Hayden M. 1952. Venous velocity in bedridden medical patients. Lancet. 2:699–700 10.1016/S0140-6736(52)91318-4
    1. Zhou J., May L., Liao P., Gross P.L., Weitz J.I. 2009. Inferior vena cava ligation rapidly induces tissue factor expression and venous thrombosis in rats. Arterioscler. Thromb. Vasc. Biol. 29:863–869 10.1161/ATVBAHA.109.185678

Source: PubMed

3
Abonnieren